Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

New feature: Introducing the Finviz Matrix

Helius Medical Technologies, Inc.

Contributing Author

Recent Articles by Helius Medical Technologies, Inc.

Sep-29	Preeminent SOL Treasury Company Helius (NASDAQ:HSDT) Announces Corporate Name Change to Solana Company and Letter of Intent with Solana Foundation HSDT +5.96% GlobeNewswire
Sep-25	Helius Announces FDA 510(k) Submission for PoNS Device Label Expansion in Stroke HSDT -8.80% GlobeNewswire
Sep-22	Helius (NASDAQ:HSDT) Begins Purchases of SOL, the Native Asset of Solana Blockchain HSDT -33.61% GlobeNewswire
Jul-21	Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation HSDT +7.64% GlobeNewswire
Jul-09	Helius Medical Technologies, Inc. Compliant with Nasdaq's Continued Listing Requirements HSDT -5.39% GlobeNewswire
Jun-27	Helius Medical Technologies Announces Reverse Stock Split HSDT -37.92% GlobeNewswire
Jun-16	Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS) Device HSDT -26.23% GlobeNewswire
Jun-12	Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting HSDT -45.89% GlobeNewswire
Jun-11	Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS) Device HSDT +31.36% GlobeNewswire
Jun-04	Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering HSDT -65.14% GlobeNewswire
Jun-04	Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria HSDT -7.11% GlobeNewswire
May-20	Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy at CMSC Annual Meeting HSDT GlobeNewswire
May-12	Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS) Device HSDT GlobeNewswire
Apr-30	Helius Medical Technologies Announces Reverse Stock Split HSDT -15.19% GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)